Brussels urges unity over AstraZeneca jab to boost public confidence

EU governments divided over whether and what restrictions if any should be imposed on its use

• Coronavirus - latest updates
• See all our coronavirus coverage

The EU's 27 member states have been urged by Brussels to bolster public confidence by coming up with a unified response to the finding by regulators that blood clots are a rare side-effect of the Oxford/AstraZeneca jab.

At a meeting of health ministers and officials from the European medicines agency (EMA), which announced the finding about the Covid vaccine while also insisting it vaccine should still be widely used, the EU's governments were divided over what restrictions if any should be imposed on its use.